v3.26.1
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]    
Net Sales $ 16,722,703 $ 9,686,975
Cost of Sales 12,538,205 5,437,484
Gross Profit 4,184,498 4,249,491
Operating Expenses    
Selling expenses 1,376,824 1,557,508
General and administrative expenses 4,736,406 6,057,477
Research and development 1,997,861
Total Operating Expenses 6,113,230 9,612,846
Loss From Operations (1,928,732) (5,363,355)
Other Income (Expenses)    
Non-operating (expense) income (1,662,565) 4,496
Loss on impairment of goodwill (218,606)
Plant, property and equipment written off (192,726)
Unrealized gain 296,420
Foreign exchange transaction income (loss) (30,075) 13,281
Interest expense, net (77,135) (31,244)
Financial expense (186,146) (182,269)
Total Other Expenses, Net (2,070,833) (195,736)
Loss Before Income Taxes (3,999,565) (5,559,091)
Income Tax Benefit (Expense) 580,987 (2,614)
Net Loss (3,418,578) (5,561,705)
Other Comprehensive (Loss) Income    
Foreign currency translation (17,899) 721
Net Loss and Comprehensive Loss $ (3,436,477) $ (5,560,984)
Weighted average shares outstanding - Basic [1] 20,684,692 3,765,727
Weighted average shares outstanding - Diluted [1] 20,684,692 3,765,727
Diluted $ (0.17) $ (1.48)
Basic $ (0.17) $ (1.48)
[1] Including 0 and 1,500 shares that were granted and vested but not yet issued for the year ended December 31, 2025 and 2024, respectively.